PlexusDx's Precision Peptide Genetic Test maps 49 peptide pathways and 150+ genetic insightsincluding GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313to identify which patients are more likely to respond robustly to semaglutide, tirzepatide, or combination protocols
For a substance or method to be added to the list, it must be determined that it meets at least two of the following three criteria: It has the potential to enhance or enhances sport performance It represents an actual or potential health risk to the athletes It violates the spirit of sport
Examining the risk of depression or self-harm associated with incretin-based therapies used to manage hyperglycaemia in patients with type 2 diabetes: a cohort study using the UK clinical practice research datalink
for 10 days)) and group 5 (ALEAP alone for 10 days)
& Bloom, K
Laugerette F, Passilly-Degrace P, Patris B, Niot I, Febbraio M, Montmayeur JP, Besnard P